Literature DB >> 30631990

Successful Treatment with SCIG of a Child with Refractory Chronic ITP.

Anna Karastaneva1,2, Daniela S Klobassa3, Milen Minkov4, Martin Benesch5,6, Markus G Seidel5,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30631990     DOI: 10.1007/s10875-018-0583-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

Review 1.  The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.

Authors:  Mark Ballow
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

2.  Cytomegalovirus can make immune thrombocytopenic purpura refractory.

Authors:  Dina DiMaggio; Alan Anderson; James B Bussel
Journal:  Br J Haematol       Date:  2009-05-09       Impact factor: 6.998

3.  How I treat refractory immune thrombocytopenia.

Authors:  Adam Cuker; Cindy E Neunert
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

4.  Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.

Authors:  Veronica Pedini; Isabella Savore; Maria Giovanna Danieli
Journal:  Isr Med Assoc J       Date:  2017-07       Impact factor: 0.892

Review 5.  Diagnosis and management of immune thrombocytopenia in childhood.

Authors:  Thomas Kühne
Journal:  Hamostaseologie       Date:  2016-10-04       Impact factor: 1.778

Review 6.  Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment.

Authors:  Markus G Seidel
Journal:  Blood       Date:  2014-08-27       Impact factor: 22.113

7.  Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?

Authors:  Philipp Scheuerlein; Larissa Pietsch; Nadezhda Camacho-Ordonez; Veronika Reiser; Smita Patel; Siobhan O Burns; Klaus Warnatz; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-07-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.